Study title: Vandenhoven G, Wouters C, Slachmuylders P et al. Biphenylacetic acid (Felbinac) 3% gel t.i.d. in patients with acute soft tissue injuries. Acta Therapeutica 1995; 21(2): 155-66.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Musculoskeletal Diseases [C05] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: FELBINAC | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: Protocol ATC 80-03P | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |